drugset / Trial / NCT02863120

Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty

NCT02863120 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is being done to evaluate the outcomes of patients undergoing total knee replacement with two different methods of local pain control:shots of liposomal bupivacaine, a long acting anesthetic, directly into the knee during surgery or anesthetic delivered continuously to the adductor canal to provide long term pain relief. The goal is to try to find a standard protocol that provides the greatest pain relief for patients undergoing total knee replacement.

Timeline

Start
2016-07
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 15 ml Other
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Bupivacaine Other / unclassified 30 ml Other
Comparator Ropivacaine Other / unclassified 550 ml Other

Indications